Abstract
A variable region gene of the T–cell receptor, Vβ8.2, is rearranged, and its product is expressed on pathogenic T cells that induce experimental autoimmune encephalomyelitis (EAE) in H–2u mice after immunization with myelin basic protein (MBP). Vaccination of these mice with naked DNA encoding Vβ8.2 protected mice from EAE. Analysis of T cells reacting to the pathogenic portion of the MBP molecule indicated that in the vaccinated mice there was a reduction in the Thl cytokines interleukin–2 (IL–2) and interferon–γ. In parallel, there was an elevation in the production of IL–4, a Th2 cytokine associated with suppression of disease. A novel feature of DNA immunization for autoimmune disease, reversal of the autoimmune response from Thl to Th2, may make this approach attractive for treatment of Thl–mediated diseases like multiple sclerosis, juvenile diabetes and rheumatoid arthritis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zamvil, S. & Steinman, L. The T lymphocyte in autoimmune encephalomyelitis. Ann. Rev. Immunol. 8, 579–621 (1990).
Zamvil, S.S. et al. Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J. Exp. Med. 167, 1586–1596 (1988).
Acha-Orbea, H. et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54, 263–273 (1988).
Urban, J.L. et al. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54, 577–592 (1988).
Sakai, K. et al. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc. Natl. Acad. Sci. USA 85, 8608–8612 (1988).
Vandenbark, A.A., Hashim, G. & Offner, H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341, 541–544 (1989).
Howell, M.D. et al. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246, 668–670 (1989).
Pardoll, D.M. & Beckerleg, A.M. Exposing the immunology of naked DNA vaccines. Immunity 3, 165–169 (1995).
Davis, H.L., Michel, M.L. & Whalen, R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2, 1847–1851 (1993).
Ulmer, J.B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745–1749 (1993).
Tang, D.C., DeVit, M. & Johnston, S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152–154 (1992).
Mosmann, T.R. & Coffman, R.L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1, 145–173 (1989).
Abbas, A.K. et al. Activation and function of CD4+ T-cell subsets. Immunol. Rev. 123, 5 (1991).
Xu, D. & Liew, F.Y. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major . Immunology 84, 173–176 (1995).
Zamvil, S.S. et al. Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells. J. Exp. Med. 168, 1181–1186 (1988).
Kuchroo, V.K. et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707–718 (1995).
Powell, M.B. et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2, 539–544 (1990).
Racke, M.K. et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180, 1961–1966 (1994).
Wraith, D.C., McDevitt, H.O., Steinman, L. & Acha-Orbea, H. T cell recognition as the target for immune intervention in autoimmune disease. Cell 57, 709–715 (1989).
Ben-Nun, A., Wekerle, H. & Cohen, I.R. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292, 60–61 (1981).
Lider, O., Reshef, T., Beraud, E., Ben-Nun, A. & Cohen, I.R. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 239, 181–183 (1988).
Zhang, J., Medaer, R., Stinissen, P., Hafler, D. & Raus, J. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261, 1451–1454 (1993).
Medaer, R., Stinissen, P., Truyen, L., Raus, J. & Zhang, J. Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: Pilot trial in multiple sclerosis. Lancet 346, 807–808 (1995).
Bourdette, D.N. et al. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides. J. Immunol. 152, 2510–2519 (1994).
Chou, Y.K. et al. Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides. J. Immunol. 152, 2520–2529 (1994).
Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A. & Weiner, H.L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265, 1237–1240 (1994).
Lehmann, P.V., Forsthuber, T., Miller, A. & Sercarz, E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155 (1992).
Brocke, S. et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343–346 (1996).
Oksenberg, J.R. et al. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362, 68–70 (1993).
Steinman, L. Escape from “horror autotoxicus”: Pathogenesis and treatment of autoimmune disease. Cell 80, 7–10 (1995).
Wucherpfennig, K.W. et al. Shared human T cell receptor Vβ usage to immun-odominant regions of myelin basic protein. Science 248, 1016 (1990).
Warren, K.G., Catz, I. & Steinman, L. The dominant T and B cell response in the central nervous system in multiple sclerosis is directed to myelin basic protein residues 86–99. Proc. Natl. Acad. Sci. USA 92, 11061–11065 (1995).
Steinman, L. Presenting an odd autoantigen. Nature 375, 739–740 (1995).
Steinman, L., Waisman, A. & Altman, D., T-cell responses in multiple sclerosis. Mol. Med. Today 1, 79–83 (1995).
Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual, edn. 2 (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989).
Davis, H.L. & Jasmin, B.J. Direct gene transfer into mouse diaphragm. FEES Lett. 333, 146–150 (1993).
Sakai, K. et al. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J. Neuroimmunol. 19, 21–32 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waisman, A., Ruiz, P., Hirschberg, D. et al. Suppressive vaccination with DNA encoding a variable region gene of the T–cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med 2, 899–905 (1996). https://doi.org/10.1038/nm0896-899
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0896-899
This article is cited by
-
Specific humoral and cellular immunity induced by Trypanosoma cruzi DNA immunization in a canine model
Veterinary Research (2013)
-
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis
Journal of Neuroinflammation (2012)
-
T-cell vaccination leads to suppression of intrapancreatic Th17 cells through Stat3-mediated RORγt inhibition in autoimmune diabetes
Cell Research (2011)
-
Strategies for enhancing DNA vaccine potency by targeting antigen-presenting cells
Frontiers of Agriculture in China (2009)
-
Multiple sclerosis therapy: An update on recently finished trials
Journal of Neurology (2007)